Crescent Capital BDC, Inc. $CCAP Position Trimmed by Cobblestone Capital Advisors LLC NY

Cobblestone Capital Advisors LLC NY lowered its stake in Crescent Capital BDC, Inc. (NASDAQ:CCAP) by 1.8% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 58,042 shares of the company’s stock after selling 1,040 shares during the period. Cobblestone Capital Advisors LLC NY’s holdings in Crescent Capital BDC were worth $818,000 as of its most recent filing with the SEC.

Other hedge funds have also modified their holdings of the company. Catalyst Capital Advisors LLC acquired a new position in shares of Crescent Capital BDC in the second quarter worth about $69,000. Catalina Capital Group LLC acquired a new position in Crescent Capital BDC during the second quarter valued at $174,000. Barnett & Company Inc. acquired a new stake in Crescent Capital BDC during the 1st quarter worth about $296,000. Ieq Capital LLC grew its stake in Crescent Capital BDC by 3.5% during the 1st quarter. Ieq Capital LLC now owns 23,518 shares of the company’s stock valued at $403,000 after acquiring an additional 793 shares in the last quarter. Finally, Almitas Capital LLC purchased a new stake in shares of Crescent Capital BDC in the first quarter worth approximately $414,000. 49.46% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other Crescent Capital BDC news, Director Raymond Barrios purchased 3,245 shares of the stock in a transaction dated Monday, August 25th. The stock was bought at an average price of $15.63 per share, for a total transaction of $50,719.35. Following the transaction, the director directly owned 19,177 shares in the company, valued at $299,736.51. This represents a 20.37% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available at the SEC website. Company insiders own 1.14% of the company’s stock.

Crescent Capital BDC Stock Up 1.6%

NASDAQ:CCAP opened at $14.53 on Tuesday. Crescent Capital BDC, Inc. has a 12 month low of $13.31 and a 12 month high of $20.19. The company’s 50-day moving average price is $14.92 and its two-hundred day moving average price is $14.96. The company has a debt-to-equity ratio of 1.22, a quick ratio of 1.27 and a current ratio of 1.27.

Crescent Capital BDC (NASDAQ:CCAP) last announced its earnings results on Wednesday, August 13th. The company reported $0.46 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.46. The company had revenue of $42.99 million during the quarter, compared to analyst estimates of $42.52 million. Crescent Capital BDC had a return on equity of 10.55% and a net margin of 24.12%. Equities analysts predict that Crescent Capital BDC, Inc. will post 2.09 EPS for the current year.

Crescent Capital BDC Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, October 15th. Investors of record on Tuesday, September 30th were issued a $0.42 dividend. The ex-dividend date was Tuesday, September 30th. This represents a $1.68 annualized dividend and a yield of 11.6%. Crescent Capital BDC’s dividend payout ratio (DPR) is currently 140.00%.

Analysts Set New Price Targets

CCAP has been the subject of a number of analyst reports. Keefe, Bruyette & Woods raised Crescent Capital BDC from a “hold” rating to a “moderate buy” rating in a research report on Tuesday, July 22nd. LADENBURG THALM/SH SH upgraded shares of Crescent Capital BDC to a “strong-buy” rating in a research note on Friday, August 15th. Finally, Zacks Research lowered shares of Crescent Capital BDC from a “hold” rating to a “strong sell” rating in a research report on Wednesday, October 15th. One equities research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Crescent Capital BDC presently has a consensus rating of “Moderate Buy” and a consensus target price of $16.33.

About Crescent Capital BDC

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.